FDA approves Spravato, nasal spray derived from Ketamine

Name: FDA approves Spravato, nasal spray derived from Ketamine
Uploaded: 2025-01-23T22:25:43Z
Description: The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

The FDA approves Spravato, a nasal spray derived from Ketamine, to help some people treat depression. Dr. Bill Hartman from UW Health shares more.

Posted January 23, 2025 4:25pm CST